Bdrx investor alert: bronstein, gewirtz and grossman, llc announces an investigation into biodexa pharmaceuticals plc and encourages investors to contact the firm

New york--(business wire)---- $bdrx #bdrx--attorney advertising--bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of biodexa pharmaceuticals plc (“biodexa” or “the company”) (nasdaq: bdrx). investors who purchased biodexa securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/bdrx. investigation details on october 4, 2024, biodexa reported updated data on progression-free and overall surviva.
BDRX Ratings Summary
BDRX Quant Ranking